The last time I wrote about Recursion Pharmaceuticals (NASDAQ:RXRX), it was with respect to a Seeking Alpha article entitled "Recursion: CDK7 Differentiation Is Initially Paying Off." With respect to ...

Given climate change, there is an urgent need to conserve natural populations of forest trees and associated ecosystems. In contrast to a growing body of literature on genomic offsets and related ...

Linear type systems permit programmers to deallocate or explicitly recycle memory, but they are severly restricted by the fact that they admit no aliasing. This paper describes a pseudo-linear type ...

Cybersecurity researchers have uncovered malicious libraries in the Python Package Index (PyPI) repository that are designed to steal sensitive information and test stolen credit card data. "The ...

The identification of ion channels expressed in neuronal function and neuronal dynamics is critical to understanding neurological disease. This program calls for advanced parameter estimation methods ...

We recently published a list of the 10 Best Performing Healthcare Stocks So Far in 2025. In this article, we are going to take a look at where Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) stands ...

A young computer scientist and two colleagues show that searches within data structures called hash tables can be much faster than previously deemed possible. Sometime in the fall of 2021, Andrew ...

Los Angeles—Artificial intelligence (AI)-based drug discovery continues to tout accelerated timelines and novel and effective treatments, yet today’s clinical success rates remain at a low 10%. On ...

Met primary endpoint of safety and tolerability in CCM patients with no treatment-related discontinuations or Grade 3 adverse events In comparison to placebo, treatment with REC-994 400 mg showed ...

You can create a release to package software, along with release notes and links to binary files, for other people to use. Learn more about releases in our docs.